CAL 123 FEM TABLET is a combination of Calcitriol, Calcium Carbonate, Calcium Orotate, Calcium Citrate, Calcium Aspartate, Soya Isoflavones, and Vitamin K2-7 which belongs to the group of medicines called Vitamin D derivatives, Calcium compounds, Phytoestrogens, and Vitamin K derivatives. It is used to prevent, treat, or manage postmenopausal osteoporosis and fractures.
Menopause is the time that marks the natural end of reproductive age for a woman, along with the cessation of the menstrual cycle and a decline in reproductive hormone levels in the body, causing bone loss (postmenopausal osteoporosis) and fractures.
Osteoporosis is a condition that causes thinning and weakening of bones because of excessive absorption of calcium from the bones. It is characterized by symptoms such as bleeding gums, weak grip strength, brittle fingernails, loss of height, frequent fractures, and neck and back pain.
CAL 123 FEM TABLET is also not recommended for use in patients with hypercalcemia (high calcium levels in the blood) and/or metastatic calcification (extra deposits of calcium in your body).
Before taking [GBNKEWYORD], inform your doctor if you are immobilized (due to an operation or any other reason) and/or have liver problems (such as non-alcoholic fatty liver disease).
CAL 123 FEM TABLET should be used with caution in pregnant and breastfeeding women only clearly necessary. CAL 123 FEM TABLET should be used with caution in children and adolescents (aged below 18 years).
The most common side effects associated with the use of CAL 123 FEM TABLET are hypercalcemia (high calcium levels in the blood), headache, skin rash, excess thirst, and nausea. abdominal pain and/or urinary tract infection. Consult your doctor if any of these symptoms worsen.
CAL 123 FEM TABLET helps in promoting bone health in postmenopausal women, where calcitriol works by aiding the body to absorb more calcium from food or supplements, which also regulates the production of parathyroid hormone (the chemical responsible for maintaining the balance between calcium and phosphorus in the body).
Calcium carbonate, calcium orotate, calcium citrate, and calcium aspartate work by facilitating calcium retention and bone accrual, which leads to consolidation and maintenance of bone mass, thus preventing bone fracture and reducing the risk of osteoporosis.
Soy isoflavones mimic the actions of oestrogen, which is a hormone that is needed for calcium deposition in the bones, thereby reversing bone loss in postmenopausal women.
Vitamin K2-7 works by increasing collagen production through osteoblastic cells and preventing calcium deposits in the arteries, thus increasing healthy bone deposits and thereby treating osteoporosis in affected individuals.
Take CAL 123 FEM TABLET as advised by your physician. Swallow the medicine with a glass of water. Do not crush or chew the medicine. Your doctor will decide the correct dose and duration for you depending upon your age, body weight and disease condition.
Stop taking CAL 123 FEM TABLET and contact your doctor if you experience any of the following side effects:
Try to take CAL 123 FEM TABLET with or just after a meal or a snack. Stick to simple meals. Avoid eating rich or spicy food. Consult your doctor if the symptom gets worse.
Try to drink plenty of cold water and sip on cold unsweetened drinks and use lip balm if your lips are dry. Brush your teeth twice daily and use mouthwash. Consult and inform your doctor if the symptom gets worse.
If CAL 123 FEM TABLET causes a headache, then take rest and drink plenty of fluids. Try to avoid drinking alcohol. Ask your doctor to recommend a painkiller. Headaches should usually go away after the first week of taking CAL 123 FEM TABLET. If it lasts more than a week or is severe, inform your doctor.
CAL 123 FEM TABLET should be used with caution during pregnancy and in women planning for pregnancy only if it is necessary. Consult your doctor before taking it.
CAL 123 FEM TABLET should be used with caution in breastfeeding women only if it is necessary. Consult your doctor before taking it.
CAL 123 FEM TABLET is unlikely to affect your ability to drive or operate machines. Consult your doctor before taking it.
CAL 123 FEM TABLET should be used with caution in patients with kidney problems such as renal osteodystrophy. Consult your doctor before taking it.
CAL 123 FEM TABLET should be used with caution in patients with liver problems such as non-alcoholic fatty liver disease. Consult your doctor before taking it.
Do not take CAL 123 FEM TABLET if you are allergic to Calcitriol, other vitamin D metabolites (such as alfacalcidol, cholecalciferol), and/or any other ingredients of this medicine. Consult your doctor before taking it.
CAL 123 FEM TABLET should be used with caution in children and adolescents (below 18 years). Consult your doctor before taking it.
CAL 123 FEM TABLET should be used with caution in elderly patients (aged above 65 years). Consult your doctor before taking it.
CAL 123 FEM TABLET is not recommended for use if you:
Before taking CAL 123 FEM TABLET, inform your doctor if you:
A. Drug-Drug Interactions:
Before taking CAL 123 FEM TABLET, inform your doctor, if you are taking any of the following medicine:
B. Drug-Food Interactions:
Avoid having vitamin D-rich foods (such as dairy products like milk, and cheese) or fortified foods (eatables to which vitamin D is added) while taking CAL 123 FEM TABLET since it may increase the risk of side effects. Consult your doctor before taking it.
Overdosage:
If you or anyone else accidentally takes too much of CAL 123 FEM TABLET, consult your doctor immediately or visit the nearby hospital. Symptoms of overdosage include signs of hypercalcemia such as loss of appetite, weight loss, nausea, vomiting, constipation, headache, sluggishness, drowsiness, and/or weakness.
Drug | : | Calcitriol, Calcium Carbonate, Calcium Orotate, Calcium Citrate, Calcium Aspartate, Soya Isoflavones, and Vitamin K2-7 |
Pharmacological Category | : | Vitamin D derivatives, Calcium compounds,Phytoestrogens, and Vitamin K derivatives |
Therapeutic Indication | : | Postmenopausal osteoporosis and fractures |
Dosage Forms | : | Tablet |
Q: What is CAL 123 FEM TABLET used for?
A: CAL 123 FEM TABLET is used to prevent, treat, or manage postmenopausal osteoporosis and fractures. Menopause is the time that marks the natural end of reproductive age for a woman, along with the cessation of the menstrual cycle and a decline in reproductive hormone levels in the body, causing bone loss (postmenopausal osteoporosis) and fractures.
Q: What happens if you take more CAL 123 FEM TABLET than your required dose?
A: If you or anyone else accidentally takes too much CAL 123 FEM TABLET, consult your doctor immediately or visit the nearby hospital. Symptoms of overdosage include signs of hypercalcemia such as loss of appetite, weight loss, nausea, vomiting, constipation, headache, sluggishness, drowsiness, and/or weakness.
Q: What side effects are seen with CAL 123 FEM TABLET?
A: The most common side effects associated with the use of CAL 123 FEM TABLET are hypercalcemia (high calcium levels in the blood), headache, skin rash, excess thirst, and nausea. abdominal pain and/or urinary tract infection. Consult your doctor if any of these symptoms worsen.
Q: Who should avoid taking CAL 123 FEM TABLET?
A: CAL 123 FEM TABLET is not recommended for use in patients allergic to calcitriol, other vitamin D metabolites (such as alfacalcidol, cholecalciferol), and/or any other ingredients of this medicine. CAL 123 FEM TABLET is also not recommended for use in patients with hypercalcemia (high calcium levels in the blood) and/or metastatic calcification (extra deposits of calcium in your body). Consult your doctor before taking CAL 123 FEM TABLET.
Q: Is CAL 123 FEM TABLET safe to use in children or elderly patients?
A: Yes, CAL 123 FEM TABLET can be used, but with caution in children and adolescents (below 18 years) and in elders (aged above 65 years). Consult your doctor before taking it.
Q: Is CAL 123 FEM TABLET safe for use by pregnant and breastfeeding women?
A: Yes, CAL 123 FEM TABLET can be used, but with caution during pregnancy and in women planning for pregnancy only if it is necessary. It is also used with caution in breastfeeding women if deemed necessary by the consulting doctor. Consult your doctor before taking CAL 123 FEM TABLET.
Q: What if I forget to take my CAL 123 FEM TABLET dose?
A: If you forgot to take your CAL 123 FEM TABLET dose, take it as soon as possible when you remember. Do not double the dose to make up for the missed dosage. Consult your doctor if you have doubts about a missed dosage.
Q: How much CAL 123 FEM TABLET can be taken in a day?
A: Take CAL 123 FEM TABLET as advised by your physician, who shall decide the correct dose and duration for you depending on your age, body weight, and disease condition.
1. Edward Giovannucci, Martin Hewison, Roger Bouillon, David Goltzman, David Feldman. The Vitamin D analogs, Eldecalcitol. Vitamin D: Volume 2: Health, Disease and Therapeutics. Fourth edition. 2018. Page 215.
2. Paul Insel, Elaine Turner, Don Ross. Calcium Supplements: Are they right for you? Discovering Nutrition. Third edition. 2010. Page 417.
3. Jan Gordeladze. Vitamin K2 and Bone Heath. Vitamin K2 is Vital for Health and Wellbeing. Edition. 2017. Page 110.
4. Brandon E. Lung; Myles L. Mowery; David E E. Komatsu. Calcitriol. NIH National Library of Medicine. National Centre for Biotechnology Information. StatPearls [Internet]. July 2022. [Accessed on 4th October 2022] https://www.ncbi.nlm.nih.gov/books/NBK526025/
5. Hamid Lorvand Amiri, Shahram Agah , Javad Tolouei Azar , Sharieh Hosseini , Farzad Shidfar , Seyedeh Neda Mousavi. Effect of daily calcitriol supplementation with and without calcium on disease regression in non-alcoholic fatty liver patients following an energy-restricted diet: Randomized, controlled, double-blind trial. NIH National Library of Medicine. National Centre for Biotechnology Information. PubMed.gov. September 2016. [Accessed on 4th October 2022] https://pubmed.ncbi.nlm.nih.gov/27720403/
6. Ji Yeon Lee, Tsz-Yin So, and Jennifer Thackray. A Review on Vitamin D Deficiency Treatment in Pediatric Patients. NIH National Library of Medicine. National Centre for Biotechnology Information. PMC PubMed Central. December 2013. [Accessed on 4th October 2022] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3979050/
7. Meghan Meehan, Sue Penckofer. The Role of Vitamin D in the Aging Adult. NIH National Library of Medicine. National Centre for Biotechnology Information. PMC PubMed Central. December 2014. [Accessed on 4th October 2022] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4399494/
8. Atnahs Pharma UK Limited. Electronic Medicines Compendium (EMC). [Revised in September 2020] [Accessed on 4th October 2022] https://www.medicines.org.uk/emc/files/pil.11802.pdf
9. PHARMED LIMITED. Cal 123 fem. [Accessed on 4th October 2022] https://www.pharmedlimited.com/women-health/cal123-fem.html
The contents of this website are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.